The search for antiviral agents against vesicular stomatitis virus, herpes simplex virus type 1 and poliovirus type 2 in plants extracts, led to the isolation of two antipoliovirus flavonoids from the medicinal plant Psiadia dentata (Cass.) DC, Asteraceae: 3-methylkaempferol and 3,4′-dimethylkaempferol. The antipoliovirus activity of both compounds was estimated by comparison with 3-methylquercetin, guanidine and Ro-090179. The most potent inhibitor of poliovirus replication was 3-methylkaempferol, and therefore we investigated its mechanism of action. We showed, using the inhibition of [3H]uridine incorporation in viral RNA and performing a dot-blot with one RNA probe specific for the poliovirus genomic strand RNA, that 3-methylkaempferol inhibits the genomic RNA synthesis of poliovirus.
BeutlerJ-AHamelEVlietinckA-JHaemersARajanPRoitmanJ-NCardellinaJ-HII & BoydM-R (1998) Structure-Activity requirements for flavone cytotoxicity and binding to tubulin. Journal of Medicinal Chemistry41: 2333–2338.
2.
BurlesonF-GChambersT-M & WiedbraukD-L (1992) Virology: A laboratory manual. pp. 250. London: Academic Press.
3.
CaliguiriA-C & TammI (1973) Guanidine and 2-(α-hydroxybenzyl)-benzimidazole (HBB): Selective inhibitors of picornavirus multiplication. In Selective Inhibitors of Viral Functions. Edited by CarterWA. Cleveland, Ohio: CRC Press, pp. 257–293.
CastrilloJ-LBergheVanden D-A & CarrascoL (1986) 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology152: 219–227.
6.
CastrilloJ-L & CarrascoL (1987) Action of 3-methylquercetin on poliovirus RNA replication. Journal of Virology61: 3319–3321.
7.
CheC-T (1991) Plants as a source of potential antiviral agents. Economical and Medicinal Plant Research5: 167–251.
8.
De MeyerNHaemersAMishraLPandeyH-KPietersL-A-CBergheVanden D-A & VlietinckA-J (1991) 4′-hydroxy-3-methoxyflavones with potent antipicornavirus activity. Journal of Medicinal Chemistry34: 736–746.
9.
DenizotF & LangR (1986) Rapid colorimetric assay for cell growth and survival — Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods89: 271–277.
10.
Fields (1988) The development and assessment of antiviral chemotherapy, vol. 1. Boca Raton: CRC Press, pp. 1–158.
11.
Fields (1988) The development and assessment of antiviral chemotherapy, vol. 2. Boca Raton: CRC Press, pp. 1–127.
GuineaR & CarrascoL (1990) Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO Journal9: 2011–2016.
14.
HamburgerMMarstonD-S & HostettmannK (1991) Search for new drugs of plant origin. Advances in Drug Research20: 167–215.
15.
HudsonJ-B (1990) Antiviral compounds from plants. Floride: CRC Press, pp. 83–99.
16.
IrurzunAPerezL & CarrascoL (1992) Involvement of membrane traffic in the replication of poliovirus genomes: Effects of brefeldin A. Virology191: 166–175.
17.
IrurzunA & CarrascoL (2001) Entry of poliovirus into cells is blocked by Valinomycin and Concanamycin A. Biochemistry40: 3589–3600.
PincusS-E & WimmerE (1986) Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: Mutations in polypeptide 2C are directly reponsible for altered guanidine sensitivityJournal of Virology60: 793–796.
ReedL-J & MuenchH (1938) A simple method of estimating fifty per cent endpoints. American Journal of Hygiene27: 493–497.
22.
RobinVBoustieJAmorosM & GirreL (1998) In vitro antiviral activity of seven Psiadia species, Asteraceae: Isolation of two antipoliovirus flavonoids from P. dentata. Pharmaceutical and Pharmacological Communications4: 61–64.
23.
RotbartH-A (2000) Antiviral therapy for enteroviruses and rhinoviruses. Antiviral Chemistry & Chemotherapy11: 261–271.
24.
SandovalI-V & CarrascoL (1997) Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. Journal of Virology71: 4679–4693.
25.
TsuchiyaYShimizuMHryamaYItohKHashimotoYNakayamaMHorieT & MoritaN (1985) Antiviral activity of natural occurring flavonoids in vitro. Chemical and Pharmaceutical Bulletin33: 3881–3885.
26.
BergheVanden D-AVlietinckA-J & Van HoofL (1986) Plant products as potential antiviral agents. Bulletin de l'Institut Pasteur84: 101–147.
27.
Van HoofLBergheVanden D-AHatfieldG-M & VlietinckA-J (1984) Plant antiviral agents; V. 3-methoxyflavones as potent inhibitors of viral-induced block of cell synthesis. Planta Medica50: 513–517.
28.
VlietinckA-JBergheVanden D-AVan HoofLVrijsenR & BoeyéA (1986) Antiviral activity of 3-methoxyflavones. Progress in Clinical and Biological Research213: 537–540.
29.
VlietinckA-JBergheVanden D-A & HaemersA (1988) Present status and prospects of flavonoids as anti-viral agents. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medicinal Properties. Edited by AR Liss, Inc. pp. 283–299. New York: Cody V, Middleton E Jr, Harbone JH & Beretz A.
30.
VlietinckA-JDe BruyneTApersS & PietersL-A (1998) Plant- derived leading compounds for chemotherapy of Human Immunodeficiency Virus (HIV). Planta Medica64: 97–109.
31.
WangY & HostettmannK (1990) Polyphenols from Psiadia trinervia (Asteraceae). Bulletin de Liaison Groupe Polyphenols15: 167–170.
